Characteristics of patients and result of intervention for long-term prescription of carbapenem
| Age [median (IQR)] | 68 (60-73.25) |
| Sex [Male, (%)] | 30 (71.4) |
| Duration of carbapenem use before intervention [days, median (IQR)] | 19 (18.0-26.5) |
| Admission to the ICU during the period of carbapenem administration [N, (%)] | 17 (40.5) |
| Site of infection [N, (%)] | |
| Pneumonia | 23 (54.8) |
| Intra-abdominal infection | 7 (16.7) |
| Bacteremia | 4 (9.5) |
| Hepatobiliary infection | 3 (7.1) |
| Neutropenic fever | 2 (4.8) |
| Deep neck infection, Surgical site infection, Urinary tract infection | |
| Recommendation for termination of carbapenem through medical records before intervention [N, (%)] | 30 (71.4) |
| Duration from intervention to discontinuation of carbapenem [days, median (IQR)] | 1 (0-3.75) |
| Compliance of intervention [N, (%)] | 40 (95.2) |
| Result of intervention [N, (%)] | |
| 1) Discontinuation of antibiotics | 19 (47.5) |
| 2) Change of narrow-spectrum antibiotics | 21 (52.5) |
| Piperacillin/tazobactam | 14 (66.6) |
| Cefepime | 2 (9.5) |
| Ceftriaxone | 2 (9.5) |
| Duration of changed antibiotics usage [days, median (IQR)] | 16 (7-26) |
| Recurred infection within 30 days after discontinuation of carbapenem [N, (%)] | 2 (4.8) |
| Mortality within 30 days after discontinuation of carbapenem [N, (%)] | 8 (19.0) |
Korean J healthc assoc Infect Control Prev 2023;28:85~91 https://doi.org/10.14192/kjicp.2023.28.1.85
© Korean J healthc assoc Infect Control Prev